01.03.2019 | Letter to the Editor
Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma
Erschienen in: Annals of Hematology | Ausgabe 8/2019
Einloggen, um Zugang zu erhalten